MMP9 and diabetic foot: Our team recently collaborated with McCarthy et al. and developed collagen/glycosaminoglycan (GAG) scaffolds activated by RALA complexed matrix metalloproteinase-9 siRNA (siRNA-MMP-9) for improving diabetic foot ulcer healing by reducing the MMP-9 expression from fibroblast [23].